Application no. and date | 01996021.0 (espacenet) (Federated) (European Patent Register), 20011130 | Patent/reg. no. and date | DK/EP 1339431, 20170628 | Publication date | 20030903 | Priority no. and date | US 250055 P, 20001130 | EP pub. no. and date |
EP 1339431 20030903 | Effective date | | Applicant/owner | Enteris BioPharma, Inc., 83 Fulton Street
Boonton, NJ 07005, US | Applicant ref. no. | P81703177DK00E | Inventor | STERN, William, 113 Surrey Lane
Tenafly, NJ 07670, US, MEHTA, Nozar, M., 14 Old Coach Road
Randolph, NJ 07869, US, RAY, Martha, V.L., 296 Nutley Avenue
Nutley, NJ 07110, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 47/64 (2017.01) , A61K 9/48 (2006.01) , A61P 19/10 (2006.01) , A61K 38/23 (2006.01) , A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 38/29 (2006.01) | Title | FORBEDRET ORAL INDGIVELSE AF PEPTIDER UNDER ANVENDELSE AF ENZYM-SPALTELIGE MEMBRANTRANSLOKATORER | Int. application no. | US2001044980 | Int. publication no. | WO2002043767 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|